Improving outcomes for women diagnosed with mucinous ovarian cancer

Grant number: 1045783 | Funding period: 2013 - 2016

Completed

Abstract

Mucinous ovarian cancer (MOC) is different from other ovarian cancers but few studies have characterized the genetic changes specific to this subtype. It is often confused with metastases from other organs and does not respond well to standard ovarian cancer therapies. If MOC is more similar to mucinous cancers from other organs than other ovarian cancers, it may be better treated with chemotherapeutics that show success with other mucinous tumours.

Related publications (6)